Abstract

In 1997 Derek Gilroy obtained his PhD from the William Harvey Research Institute, University of London and thereafter received postdoctoral training jointly at the University of Houston Texas and at Academia Sinica, Taipei, Taiwan from 1998-2000. After which time, he returned to the William Harvey Research Institute for a further 4 years. In 2004, Derek was appointed as New Blood lecturer funded as a Wellcome Trust Career Development Fellow at the Division of Medicine, Rayne Building, University College London. In 2009 he became a Wellcome Trust Senior Research Fellow and in 2010 was promoted to Professor of Experimental Immunology. At University College he is now Head of Dept. Experimental and Translational Medicine and is Interim Director, Division of Medicine. Using rodent and novel human models of experimental medicine he has pioneered research examining the molecular and biochemical pathways that regulates the resolution of acute immune reactions. Professor Gilroy has won the Bayer International Young Investigator Award (2005), the Norvartis Award (2007), and the Peter Dressel award, 2020. He is a Fellow of the British Pharmacological Society and a member of the British Immunological Society and the Henry Kunkel Society, New York.